logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Ovarian Neoplasms

    FiltersReset Filters
    14 results

    • carboplatin

      (Carboplatin)
      Gland Pharma Limited
      Usage: Carboplatin injection is indicated for the initial treatment of advanced ovarian carcinoma in combination with other chemotherapy agents, and for palliative treatment of recurrent ovarian carcinoma after prior chemotherapy, including in patients previously treated with cisplatin.

    • carboplatin

      (CARBOPLATIN)
      Eugia US LLC
      Usage: Carboplatin injection is indicated for the initial and palliative treatment of advanced ovarian carcinoma, used in combination with other approved chemotherapy agents. It is effective for patients who have recurrent ovarian carcinoma after prior treatment, including those previously treated with cisplatin.

    • cisplatin

      (Cisplatin)
      Accord Healthcare
      Usage: Cisplatin injection is indicated for the treatment of advanced testicular, ovarian, and bladder cancers.

    • cisplatin

      (Cisplatin)
      BluePoint Laboratories
      Usage: Cisplatin injection is indicated for the treatment of advanced testicular cancer, advanced ovarian cancer, and advanced bladder cancer.

    • cisplatin

      (Cisplatin)
      Teva Parenteral Medicines, Inc.
      Usage: Cisplatin Injection is indicated for the treatment of advanced testicular cancer, advanced ovarian cancer, and advanced bladder cancer.

    • cisplatin

      (CISplatin)
      Apotex Corp.
      Usage: Cisplatin Injection is indicated for use in combination therapy for metastatic testicular and ovarian tumors, post-surgery/radiotherapy. It is also used as a single agent for advanced transitional cell bladder cancer when local treatments are not viable.

    • doxorubicin hydrochloride

      (Doxorubicin Hydrochloride)
      Dr. Reddy's Laboratories Inc.
      Usage: Doxorubicin hydrochloride liposome injection is indicated for treating recurrent or progressive ovarian cancer after platinum chemotherapy, AIDS-related Kaposi’s sarcoma post-chemotherapy failure or intolerance, and in combination with bortezomib for multiple myeloma in patients with prior therapy but no previous bortezomib treatment.

    • doxorubicin hydrochloride liposome

      (Doxorubicin Hydrochloride Liposome)
      Baxter Healthcare Corporation
      Usage: Doxorubicin hydrochloride liposome injection is indicated for treating advanced ovarian cancer after platinum therapy failure, AIDS-related Kaposi’s sarcoma post-chemotherapy failure or intolerance, and multiple myeloma in combination with bortezomib in patients having received prior therapy.

    • gemcitabine

      (GEMCITABINE HYDROCHLORIDE)
      Meitheal Pharmaceuticals Inc.
      Usage: Gemcitabine for injection is indicated for advanced ovarian cancer (post-platinum therapy), metastatic breast cancer (after anthracycline failure), inoperable non-small cell lung cancer, and as first-line treatment for locally advanced or metastatic pancreatic adenocarcinoma.

    • gemcitabine

      (Gemcitabine hydrochloride)
      Meitheal Pharmaceuticals Inc.
      Usage: Gemcitabine Injection is indicated for treating advanced ovarian cancer (post-platinum therapy), metastatic breast cancer (after anthracycline failure), non-small cell lung cancer (inoperable or metastatic), and as first-line therapy for advanced or metastatic pancreatic cancer in patients previously treated with fluorouracil.